Blue Lotus China New Economy Research, Blue Lotus Research Institute

Eric Wen

Blue Lotus China New Economy Research

China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

Thematic (Sector/Industry)

<ul>
<li>Following existing home last week, new home sales also posted positive YoY growth. </li>
<li>LI is getting ready for its major battle of the year with BEV launch. It is focused, but we doubt it is enough;</li>
<li>MNSO guided down its C4Q24 and we believe it will miss 2025 as well. Offline grocery is under constant assault by O2O and online e-commerce. </li>
</ul>


Following existing home last week, new home sales also posted positive YoY growth. 
LI is getting ready for its major battle of the year with BEV launch. It is focused, but we doubt it is enough;
MNSO guided down its C4Q24 and we believe it will miss 2025 as well. Offline grocery is under constant assault by O2O and online e-commerce. 


[Blue Lotus China New Consumer Weekly, 9/52] New Home Sales Also Turned Positive YoY

Asset Allocation & Fund Positioning, Copley Fund Research

Steven Holden

Asset Allocation & Fund Positioning

Copley Fund Research

Copley Fund Research provide research and data on asset allocation among Global and Emerging Market equity funds.  The analysis details absolute and relative positioning across countries, sectors and industries together with highly granular data on single stock and single fund allocations.  The data is updated monthly with time series going back to January 2011.

Global Research - Analysis of 165 prominent Global equity funds, combined AUM $335bn
GEM Research - Analysis of 127 prominent global EM equity funds, combined AUM $250bn

Asset Allocation - Global and GEM Equity

Equity Bottom-Up

<ul>
<li>Trip Com, Contemporary Amperex Technology and Xiaomi all hit fresh highs in EM fund ownership.</li>
<li>Rotation in all three was among the most positive across all China stocks, with all measures of fund ownership moving higher.</li>
<li>Conviction opens from GIB, Putnam and Aubrey we among the funds driving ownership higher.</li>
</ul>


Trip Com, Contemporary Amperex Technology and Xiaomi all hit fresh highs in EM fund ownership.
Rotation in all three was among the most positive across all China stocks, with all measures of fund ownership moving higher.
Conviction opens from GIB, Putnam and Aubrey we among the funds driving ownership higher.


Breaking New Ground: Xiaomi, Trip Com and CATL Hit Record Highs

<ul>
<li>A translated article shows why Chinese are refrained from buying new homes but not so on buying existing homes. The Chinese <a href="https://docs.google.com/document/d/1pMRYOjIIzxxU1G_J90dNvf_zUKNuU_LYOhnWrtM5O5I/edit?tab=t.0" target="_blank" rel="noopener">link</a> is here. <a href="https://docs.google.com/document/d/13W_8_9qyOHx2RIOYF2rGKEyHmPDO9eO5-nE8Pa5IADk/edit?tab=t.0" target="_blank" rel="noopener">English</a> here by Qwen;</li>
<li>XPeng, Xiaomi, Zeekr and BYD recovered above the line post CNY in EV delivery, LI, Tesla, LEAP and Luxeed in line, AITO, Deepal and NIO are below the line;</li>
<li>CATL's JV with Didi is a serious threat to NIO.</li>
</ul>


A translated article shows why Chinese are refrained from buying new homes but not so on buying existing homes. The Chinese link is here. English here by Qwen;
XPeng, Xiaomi, Zeekr and BYD recovered above the line post CNY in EV delivery, LI, Tesla, LEAP and Luxeed in line, AITO, Deepal and NIO are below the line;
CATL's JV with Didi is a serious threat to NIO.


[Blue Lotus China New Consumer Weekly, 8/52] Existing Home Recovers First Post CNY

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>Xtapli is looking to raise around US$242m via a primary placement, after having raised US$145m in Jan 2025.</li>
<li>QuantumPharm is a R&amp;D platform, utilizing quantum physics-based first-principles calculation, advanced AI, high-performance cloud computing, and scalable and standardized robotic automation to provide drug and material science R&amp;D solutions.</li>
<li>In this note, we will talk about the placement and run the deal through our ECM framework.</li>
</ul>


Xtapli is looking to raise around US$242m via a primary placement, after having raised US$145m in Jan 2025.
QuantumPharm is a R&amp;D platform, utilizing quantum physics-based first-principles calculation, advanced AI, high-performance cloud computing, and scalable and standardized robotic automation to provide drug and material science R&amp;D solutions.
In this note, we will talk about the placement and run the deal through our ECM framework.


Xtapli Placement - Questionable Timing. An AI Momentum Play, at Best

Asia L/S Equity PM/Macro/Thematic Idea Generation

Rikki Malik

Cross Asset Strategy

<ul>
<li>Risk reward favours this shift in allocation between these markets</li>
<li>Weakness in HK/China markets in Q1 as President Trump takes office will provide an opportunity</li>
<li>China continues to incrementally promote consumption as the new lever of growth</li>
</ul>


Risk reward favours this shift in allocation between these markets
Weakness in HK/China markets in Q1 as President Trump takes office will provide an opportunity
China continues to incrementally promote consumption as the new lever of growth


2025 High Conviction Idea: The Case for a Rotation Out of India into HK/China Part 2

China

Contemporary Amperex Technology Co., Limited. operates as a battery products manufacturing company. The Company produces and sells power battery materials, energy storage batteries energy storage battery cells, systems, and other products. Contemporary Amperex Technology also provides batteries recycling services.

Contemporary Amperex Technology (CATL) (300750 CH)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Contemporary Amperex Technology (CATL) (300750 CH)

[Blue Lotus China New Consumer Weekly, 9/52] New Home Sales Also Turned Positive YoY

Latest week saw positive YoY growth in new home sales, LI prepares for major battle with BEV launch, MNSO guidance down for C4Q24 and likely to...

Blue Lotus Research Institute

Breaking New Ground: Xiaomi, Trip Com and CATL Hit Record Highs

Strong rotation pushes Trip Com, Contemporary Amperex Technology and Xiaomi Corp to fresh highs in EM active fund ownership.

Steven Holden

[Blue Lotus China New Consumer Weekly, 8/52] Existing Home Recovers First Post CNY

Chinese prefer buying existing homes over new ones, XPeng, Xiaomi, Zeekr, and BYD lead in EV delivery post CNY, CATL's JV with Didi poses a threat...

Blue Lotus Research Institute

Xtapli Placement - Questionable Timing. An AI Momentum Play, at Best

Xtapli is looking to raise around US$242m via a primary placement, after having raised US$145m in Jan 2025. In this note, we talk about the deal...

Sumeet Singh

2025 High Conviction Idea: The Case for a Rotation Out of India into HK/China Part 2

With the HSI (22,700)and the HSTech index (5,500) hitting resistance levels, we would sell SOME here. We will likely go higher but may not go...

Rikki Malik

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

[Blue Lotus China New Consumer Weekly, 9/52] New Home Sales Also Turned Positive YoY

​Latest week saw positive YoY growth in new home sales, LI prepares for major battle with BEV launch, MNSO guidance down for C4Q24 and likely to...

Blue Lotus Research Institute

Breaking New Ground: Xiaomi, Trip Com and CATL Hit Record Highs

Strong rotation pushes Trip Com, Contemporary Amperex Technology and Xiaomi Corp to fresh highs in EM active fund ownership.

Steven Holden

[Blue Lotus China New Consumer Weekly, 8/52] Existing Home Recovers First Post CNY

​Chinese prefer buying existing homes over new ones, XPeng, Xiaomi, Zeekr, and BYD lead in EV delivery post CNY, CATL's JV with Didi poses a threat...

Blue Lotus Research Institute

Xtapli Placement - Questionable Timing. An AI Momentum Play, at Best

Xtapli is looking to raise around US$242m via a primary placement, after having raised US$145m in Jan 2025. In this note, we talk about the deal...

Sumeet Singh

2025 High Conviction Idea: The Case for a Rotation Out of India into HK/China Part 2

With the HSI (22,700)and the HSTech index (5,500) hitting resistance levels, we would sell SOME here. We will likely go higher but may not go...

Rikki Malik

Latest week saw positive YoY growth in new home sales, LI prepares for major battle with BEV launch, MNSO guidance down for C4Q24 and likely to...

Chinese prefer buying existing homes over new ones, XPeng, Xiaomi, Zeekr, and BYD lead in EV delivery post CNY, CATL's JV with Didi poses a threat...